Cabergoline and fatigue Patient Reports February 12, 2012

Cabergoline Side Effects Report #4971362-1
Cabergoline side effect was reported by a Pharmacist from GERMANY on Mar 24, 2006. Female patient, 61 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: abdominal distension, fatigue, hearing impaired, narcolepsy, pancreatic insufficiency, rectal haemorrhage. Cabergoline dosage: 1 MG, ORAL. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4680723-X
Cabergoline side effect was reported by a Physician from on May 19, 2005. Female patient, weighting 132.3 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dyspnoea exertional, endocarditis , fatigue, hyperkinesia, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with RESTEX, MADOPAR. Patient recovered.

Cabergoline Side Effects Report #6111683-2
Cabergoline side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2009. Female patient, 45 years of age, weighting 180.0 lb, was diagnosed with prolactinoma and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: abdominal discomfort, asthenia, chest pain , confusional state, dizziness , fatigue, fear, feeling abnormal, headache . Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #4634368-8
Cabergoline side effect was reported by a Physician from on Mar 28, 2005. Male patient, 84 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, cough, fatigue, loss of consciousness. Cabergoline dosage: 2 MG DAILY, ORAL; 4 MG DAILY ORAL; 0.5 MG DAILY, ORAL. During the same period patient was treated with MADOPAR, ENTACAPONE, CLOZAPINE. Patient died on 09/19/2004.


Cabergoline Side Effects Report #4939584-3
Cabergoline side effect was reported by a Physician from FINLAND on Feb 27, 2006. Female patient, 70 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, atelectasis, cardiac failure, crohn's disease , dehydration, fatigue, hypotonia, infection . Cabergoline dosage: 5 MG (DAILY), ORAL. During the same period patient was treated with DUREKAL, MOVICOL, MADOPAR, EFFORTIL, VESIX, TENOX, TRIMOPAN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4942849-2
Cabergoline side effect was reported by a Physician from FINLAND on Feb 27, 2006. Female patient, 70 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, atelectasis, cardiac failure, crohn's disease , dehydration, fatigue, hypotonia, infection . Cabergoline dosage: 5 MG (DAILY), ORAL. During the same period patient was treated with DUREKAL, MOVICOL, MADOPAR, EFFORTIL, VESIX, TENOX, TRIMOPAN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5133765-4
Cabergoline side effect was reported by a Physician from GERMANY on Oct 05, 2006. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dizziness , fall , fatigue, gait disturbance, illusion. Cabergoline dosage: 1.5 MG (1 D), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.

Cabergoline Side Effects Report #6025156-9
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Dec 16, 2008. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alopecia, aortic valve incompetence, arrhythmia , delusion, dyspnoea, fatigue, hypertension, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4MG PER DAY. During the same period patient was treated with NACOM. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4942887-X
Cabergoline side effect was reported by a Pharmacist from JAPAN on Feb 28, 2006. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, fatigue. Cabergoline dosage: 1.5 MG ORAL. During the same period patient was treated with MENESIT, NAUZELIN. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4971592-9
Cabergoline side effect was reported by a Health Professional from JAPAN on Mar 29, 2006. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, fatigue. Cabergoline dosage: 1.5 MG; ORAL. During the same period patient was treated with MENESIT, NAUZELIN. Patient was hospitalized. Patient recovered.